Assessment of hand hygiene practices among nurses at a regional hospital in Kandahar, Afghanistan: A cross-sectional study based on the World Health Organization (WHO) ‘Your 5 Moments for Hand Hygiene’ guidelines by Abdul Qadeer Baseer, Asmatullah Usmani, Shafiqullah Mushfiq, Mohammad Hassan Hassand, Bilal Ahmad Rahimi, Abdul Wahid Monib, Mohammad Salim Daqiq, Parwiz Niazi

Subjects: Get full text

Total body irradiation-based myeloablative conditioning for acute lymphoblastic leukaemia patients undergoing allogeneic haematopoietic stem cell transplantation: the best way to prevent relapse in a real-world scenario by Mario Delia, Vito Pier Gagliardi, Francesco Tarantini, Corinne Contento, Daniela Di Gennaro, Olga Battisti, Camilla Presicce, Immacolata Attolico, Paola Carluccio, Francesco Albano, Pellegrino Musto

Get full text

Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizumab by L. Johnetta Blakely, Sabine Oskar, Ian Kudel, Ashley Roush, Zoya Shamsi, Toni Perry, Annette Christianson, Brittni Smith, Thomas Burke

Subjects:

Frances Stonor Saunders, The Cultural Cold War: The CIA and the World of Arts and LettersSteven Belletto and Daniel Grausam (eds.), American Literature and Culture in an Age of Cold War: A Critical Reassessment by Will Norman

Get full text

Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm by Scott Goulden, Qin Shen, Robert L. Coleman, Cara Mathews, Matthias Hunger, Ankit Pahwa, Rene Schade

“…IPTW-adjusted median OS for dostarlimab (N=143) was not estimable (95% CI, 19.4–not estimable) versus 13.1 months (95% CI, 8.3-15.9) for real-world treatments (N = 185). Median TTD was 11.7 months (95% CI, 6.0-38.7) for dostarlimab and 5.3 months (95% CI, 4.1-6.0) for the real-world cohort. …”
Get full text

THE PROBLEM ОF HUMAN IDENTITY ІN POSTMODERN WORLD VIEW ПРОБЛЕМА ЧЕЛОВЕЧЕСКОЙ ИДЕНТИЧНОСТИ В ПОСТМОДЕРНИСТСКОЙ КАРТИНЕ МИРА ПРОБЛЕМА ЛЮДСЬКОЇ ІДЕНТИЧНОСТІ У ПОСТМОДЕРНІЙ КАРТИНІ СВІТУ by T. V. Danylova

Get full text

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system by Ruichen Gao, Wenjun Liang, Jintao Chen, Mingxia Yang, Xiaowei Yu, Xiaohua Wang

Get full text

Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema by Kai Ching Peter Leung, Sunny, Chi Lik Au

Get full text

Mondes hispaniques, globalité, réflexivité by Romain Bonnet

Subjects: “…Hispanic worlds…”
Get full text

Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational study: a brief report by Urpo Kiiskinen, Grace Segall, Hollie Bailey, Cameron Forshaw, Tarun Puri

Subjects: Get full text

Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil by Juan Manuel Palacios, Pratiksha Kapse, Vanessa Cortes, Marcio Augusto Averbeck, Alberto Budia Alba, Suryakant Somvanshi, Danilo Souza Lima da Costa Cruz, Fiona Pereira

Subjects: Get full text

Real‐World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)‐Mutant Metastatic Non‐Small Cell Lung Cancer, From a US‐Based Clinico‐Genomic Database by Sarah Waliany, Misako Nagasaka, Leah Park, Clara Lam, Zoe Jiang, Feng Lin, Joel W. Neal

“…The median (95% confidence interval [CI]) real‐world (rw) progression‐free survival in first‐line was 5.5 (4.8, 6.2) months and 3.0 (2.3, 4.2) months in second‐line. …”
Get full text

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma by Rossana Di Staso, Beatrice Casadei, Frederick L. Locke, Michael Jain, Timothy J. Voorhees, Adam S. Kittai, Mariana Bastos-Oreiro, Antonio Gutiérrez, Alejandro Martin Garcia-Sancho, Maria Jose Terol, Monica Mead, Michael J. Maranzano, Gloria Iacoboni, Pere Barba, Mi Kwon, Rebeca Bailen, Juan Luis Reguera-Ortega, Agrima Mian, Brian Hill, Emmanuel Bachy, Franck Morschhauser, Roch Houot, Catherine Thieblemont, Steven Le Gouill, Riccardo Masetti, Davide Gori, Alessandro Broccoli, Pier Luigi Zinzani, Lisa Argnani

Get full text

Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States by Bruno Emond, Carmine Rossi, Rachel Rogers, Patrick Lefebvre, Marie-Hélène Lafeuille, Prina Donga

Get full text

L’Amérique des temps profonds : jalons pour une géo-logique des récits, de John McPhee (Annals of the Former World, 1998) à Herman Melvillle (Pierre, 1852) by Bruno Monfort

Subjects: Get full text

Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice by Marwa Al‐Badri, Shilton Dhaver, Osama Hamdy

Subjects: Get full text

Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece by Panagiotis Angelopoulos, Titos Markopoulos, Lazaros Lazarou, Andreas Skolarikos, Panagiotis Stamatakos, Georgios I. Papadopoulos, Charalampos Fragkoulis, Konstantinos Ntoumas, Napoleon Moulavasilis, Panagiotis Levis, Dimitrios Papanikolaou, Ioannis Sokolakis, Konstantinos Hatzimouratidis, Charalampos Tzanetakos, Marina Psarra, George Mavridoglou, Konstantinos Skriapas, Dimitra Akrivou, Dimitrios Karagiannis, Christos Noutsos, Andreas Georgiou, Konstantinos Hastazeris, George Gourzoulidis, Dionysios Mitropoulos

“…Conclusions: This real-world study demonstrates that SII-ONCO-BCG is an effective and safe treatment for patients with intermediate- and high-risk NMIBC.…”
Get full text

Regulating the international activities of Russian higher education institutions by V. V. Bondarenko, N. A. Nazarova, K. S. Taisheva, D. P. Penzina

Subjects: Get full text

PROSPECTS FOR THE SECOND WAVE OF THE GLOBAL FINANCIAL AND ECONOVIC CRISIS by V. F. Artyushkin

Subjects: “…current situation at the world oil market…”
Get full text